These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29684320)

  • 1. Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil.
    Brito WI; Alves-Junior ER; Oliveira RM; Souto FJD
    Braz J Infect Dis; 2018; 22(3):166-170. PubMed ID: 29684320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
    J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A seroprevalence in public school children in Campos dos Goytacazes, Rio de Janeiro State, Brazil, prior to the introduction of the hepatitis A universal childhood vaccination.
    Kury CM; Pinto MA; Silva JP; Cruz OG; Vitral CL
    Cad Saude Publica; 2016 Nov; 32(11):e00175614. PubMed ID: 27982290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
    Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Souto FJD; de Brito WI; Fontes CJF
    Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
    Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
    J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
    Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C
    J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.
    Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D
    Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina: High Prevalence of Protective Antibodies up to 9 Years After Vaccination.
    Urueña A; González JE; Rearte A; Pérez Carrega ME; Calli R; Pagani MF; Uboldi A; Vicentín R; Caglio P; Cañero-Velasco MC; Gentile A; Ramonet M; Vizzotti C
    Pediatr Infect Dis J; 2016 Dec; 35(12):1339-1342. PubMed ID: 27636725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine.
    de Brito WI; de Oliveira RM; Silva J; Tubarão LN; Bom APDA; Melgaço JG; Pinto MA; Souto FJD
    J Viral Hepat; 2023 Jul; 30(7):615-620. PubMed ID: 36807662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
    Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].
    Kong Q; Yan BY; Lyu JJ; Feng Y; Liu JY; Song LZ; Xu Q; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):480-483. PubMed ID: 28592089
    [No Abstract]   [Full Text] [Related]  

  • 18. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine testing for IgG antibodies against hepatitis A virus in Israel.
    Samuels N
    BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.